IL33 and triple-A syndrome: The results confirmed IL-33 suppresses AAA by enhancing Tregs expansion and activity, indicating that regimens that reprogram IL-33 or increase endogenous IL-33 expression may limit the progression of mature AAA or prevent the development of human AAA (77).